Early Recognition and Referral of Patients With Axial Spondyloarthritis: A GameOn! Challenge

0.50 CME
0.50 ABIM MOC
30 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Early Recognition and Referral of Patients With Axial Spondyloarthritis: A GameOn! Challenge

Overview

Provider Statement

This continuing medical education activity is provided by the Cleveland Clinic Foundation Center for Continuing Education. Cleveland Clinic

Educational Partner:


Support Statement

This activity is supported by an educational grant from Pfizer, Inc.


Activity Description

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that primarily affects the sacroiliac joints and spine. Subtypes of axSpA include nonradiographic axSpA and radiographic axSpA, also known as ankylosing spondylitis, in which definitive damage to the sacroiliac joints can be observed via x-ray. Differentiating inflammatory back pain from mechanical back pain is extremely important for the timely diagnosis of axSpA. Delayed or inadequate treatment may decrease quality of life and lead to poor long-term outcomes, including irreversible loss of spinal function. In this CME activity, participants will play GameOn!, a quiz of knowledge and confidence, in which they will answer questions designed to hone their skills for the timely recognition, workup, and referral of patients with axSpA. Faculty will also quiz learners on common comorbidities and recommended treatment modalities.


Target Audience

The intended audience for this activity is physical medicine and rehabilitation (PM&R) physicians, family medicine physicians, internal medicine physicians, sports and orthopedic medicine physicians, and other health care professionals involved in the management of patients with axial spondyloarthritis and related conditions.


Learning Objective

Upon successful completion of this educational activity, participants should be better able to:

  • Differentiate inflammatory back pain from mechanical back pain based on clinical symptomology, risk factors, and underlying pathophysiology.
  • Identify patients with symptoms of axial spondyloarthritis (axSpA) and refer to a specialist as necessary.
  • Assess patients with axSpA for comorbidities and manage accordingly.
  • Review recommendations for early referral and pharmacotherapies that can be administered in the clinical setting to manage patients with axSpA.

Activity Directors

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Vice Chair of Rheumatology
Director, Arthritis and Musculoskeletal Center
Cleveland Clinic
Assistant Professor
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, OH

Marina Magrey, MD
Professor of Medicine
Case Western Reserve University School of Medicine
Division Chief of Rheumatology
University Hospital Cleveland
Cleveland, OH


Reviewer

Sarah Keller, MD


Accreditation

Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 0.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, August 30, 2021 to August 29, 2022.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objective, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Cleveland Clinic Foundation Center for Continuing Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty members have indicated that they may have a relationship which, in the context of their contribution, could be perceived as a potential conflict of interest:

Activity Chair and Faculty report the following relationship(s)

Leonard H. Calabrese, DO
Consulting Fee: AbbVie, Bristol Myers Squibb, Crescendo, Genentech, Gilead, GlaxoSmithKline, Janssen, Lilly, Pfizer, Regeneron, Sanofi-Genzyme, UCB
Speakers Bureau: AbbVie, Bristol Myers Squibb, Celgene, Genentech, Janssen, Lilly, Regeneron, Sanofi, UCB

M. Elaine Husni, MD, MPH
Consulting Fee: AbbVie, Bristol Myers Squibb, Janssen, Lilly, Novartis, Pfizer, UCB

Marina Magrey, MD
Consulting Fee: AbbVie, Eli Lilly, Novartis, Pfizer, UCB
Contracted Research: AbbVie, UCB

Reviewer reports the following relationship(s)

Sarah Keller, MD
No relevant financial relationships to disclose.

Cleveland Clinic Foundation Center for Continuing Education and Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Cleveland Clinic Foundation Center for Continuing Education and Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non—FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Cleveland Clinic Foundation Center for Continuing Education and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Cleveland Clinic Foundation Center for Continuing Education or Vindico Medical Education. Neither Cleveland Clinic Foundation Center for Continuing Education, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com